Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis

Abstract Although plasma phospholipid transfer protein (PLTP) has been mainly studied in the context of atherosclerosis, it shares homology with proteins involved in innate immunity. Here, we produced active recombinant human PLTP (rhPLTP) in the milk of new lines of transgenic rabbits. We successfu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Valérie Deckert, Stéphanie Lemaire, Pierre-Jean Ripoll, Jean-Paul Pais de Barros, Jérôme Labbé, Caroline Chabert-Le Borgne, Véronique Turquois, Guillaume Maquart, Delphine Larose, Nicolas Desroche, Franck Ménétrier, Naig Le Guern, Lorène J. Lebrun, Catherine Desrumaux, Thomas Gautier, Jacques Grober, Charles Thomas, David Masson, Louis-Marie Houdebine, Laurent Lagrost
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/38bc086aee0d4b64bfb9adb2801c05a8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:38bc086aee0d4b64bfb9adb2801c05a8
record_format dspace
spelling oai:doaj.org-article:38bc086aee0d4b64bfb9adb2801c05a82021-12-02T15:05:28ZRecombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis10.1038/s41598-017-03285-92045-2322https://doaj.org/article/38bc086aee0d4b64bfb9adb2801c05a82017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03285-9https://doaj.org/toc/2045-2322Abstract Although plasma phospholipid transfer protein (PLTP) has been mainly studied in the context of atherosclerosis, it shares homology with proteins involved in innate immunity. Here, we produced active recombinant human PLTP (rhPLTP) in the milk of new lines of transgenic rabbits. We successfully used rhPLTP as an exogenous therapeutic protein to treat endotoxemia and sepsis. In mouse models with injections of purified lipopolysaccharides or with polymicrobial infection, we demonstrated that rhPLTP prevented bacterial growth and detoxified LPS. In further support of the antimicrobial effect of PLTP, PLTP-knocked out mice were found to be less able than wild-type mice to fight against sepsis. To our knowledge, the production of rhPLTP to counter infection and to reduce endotoxemia and its harmful consequences is reported here for the first time. This paves the way for a novel strategy to satisfy long-felt, but unmet needs to prevent and treat sepsis.Valérie DeckertStéphanie LemairePierre-Jean RipollJean-Paul Pais de BarrosJérôme LabbéCaroline Chabert-Le BorgneVéronique TurquoisGuillaume MaquartDelphine LaroseNicolas DesrocheFranck MénétrierNaig Le GuernLorène J. LebrunCatherine DesrumauxThomas GautierJacques GroberCharles ThomasDavid MassonLouis-Marie HoudebineLaurent LagrostNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-16 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Valérie Deckert
Stéphanie Lemaire
Pierre-Jean Ripoll
Jean-Paul Pais de Barros
Jérôme Labbé
Caroline Chabert-Le Borgne
Véronique Turquois
Guillaume Maquart
Delphine Larose
Nicolas Desroche
Franck Ménétrier
Naig Le Guern
Lorène J. Lebrun
Catherine Desrumaux
Thomas Gautier
Jacques Grober
Charles Thomas
David Masson
Louis-Marie Houdebine
Laurent Lagrost
Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis
description Abstract Although plasma phospholipid transfer protein (PLTP) has been mainly studied in the context of atherosclerosis, it shares homology with proteins involved in innate immunity. Here, we produced active recombinant human PLTP (rhPLTP) in the milk of new lines of transgenic rabbits. We successfully used rhPLTP as an exogenous therapeutic protein to treat endotoxemia and sepsis. In mouse models with injections of purified lipopolysaccharides or with polymicrobial infection, we demonstrated that rhPLTP prevented bacterial growth and detoxified LPS. In further support of the antimicrobial effect of PLTP, PLTP-knocked out mice were found to be less able than wild-type mice to fight against sepsis. To our knowledge, the production of rhPLTP to counter infection and to reduce endotoxemia and its harmful consequences is reported here for the first time. This paves the way for a novel strategy to satisfy long-felt, but unmet needs to prevent and treat sepsis.
format article
author Valérie Deckert
Stéphanie Lemaire
Pierre-Jean Ripoll
Jean-Paul Pais de Barros
Jérôme Labbé
Caroline Chabert-Le Borgne
Véronique Turquois
Guillaume Maquart
Delphine Larose
Nicolas Desroche
Franck Ménétrier
Naig Le Guern
Lorène J. Lebrun
Catherine Desrumaux
Thomas Gautier
Jacques Grober
Charles Thomas
David Masson
Louis-Marie Houdebine
Laurent Lagrost
author_facet Valérie Deckert
Stéphanie Lemaire
Pierre-Jean Ripoll
Jean-Paul Pais de Barros
Jérôme Labbé
Caroline Chabert-Le Borgne
Véronique Turquois
Guillaume Maquart
Delphine Larose
Nicolas Desroche
Franck Ménétrier
Naig Le Guern
Lorène J. Lebrun
Catherine Desrumaux
Thomas Gautier
Jacques Grober
Charles Thomas
David Masson
Louis-Marie Houdebine
Laurent Lagrost
author_sort Valérie Deckert
title Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis
title_short Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis
title_full Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis
title_fullStr Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis
title_full_unstemmed Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis
title_sort recombinant human plasma phospholipid transfer protein (pltp) to prevent bacterial growth and to treat sepsis
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/38bc086aee0d4b64bfb9adb2801c05a8
work_keys_str_mv AT valeriedeckert recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT stephanielemaire recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT pierrejeanripoll recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT jeanpaulpaisdebarros recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT jeromelabbe recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT carolinechabertleborgne recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT veroniqueturquois recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT guillaumemaquart recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT delphinelarose recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT nicolasdesroche recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT franckmenetrier recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT naigleguern recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT lorenejlebrun recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT catherinedesrumaux recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT thomasgautier recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT jacquesgrober recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT charlesthomas recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT davidmasson recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT louismariehoudebine recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
AT laurentlagrost recombinanthumanplasmaphospholipidtransferproteinpltptopreventbacterialgrowthandtotreatsepsis
_version_ 1718388822109061120